PALE
MCID: PST092
MIFTS: 29

Posttransplant Acute Limbic Encephalitis (PALE)

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Posttransplant Acute Limbic Encephalitis

MalaCards integrated aliases for Posttransplant Acute Limbic Encephalitis:

Name: Posttransplant Acute Limbic Encephalitis 59
Pale 59

Classifications:

Orphanet: 59  
Rare neurological diseases


External Ids:

Orphanet 59 ORPHA163921

Summaries for Posttransplant Acute Limbic Encephalitis

MalaCards based summary : Posttransplant Acute Limbic Encephalitis, also known as pale, is related to clear cell acanthoma and deficiency anemia. The drugs mometasone furoate and Dexlansoprazole have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and breast.

Related Diseases for Posttransplant Acute Limbic Encephalitis

Diseases related to Posttransplant Acute Limbic Encephalitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 228)
# Related Disease Score Top Affiliating Genes
1 clear cell acanthoma 11.9
2 deficiency anemia 11.3
3 obesity, early-onset, with adrenal insufficiency and red hair 11.2
4 pernicious anemia 11.2
5 oculocutaneous albinism 11.2
6 biliary atresia 11.2
7 hepatitis b 11.2
8 syncope 11.2
9 iron-refractory iron deficiency anemia 11.2
10 anemia, sideroblastic, 1 11.2
11 cardiomyopathy, infantile histiocytoid 11.1
12 glucosephosphate dehydrogenase deficiency 11.1
13 thoracic outlet syndrome 11.1
14 tietz albinism-deafness syndrome 11.0
15 clouston syndrome 11.0
16 optic atrophy 1 11.0
17 pyruvate kinase deficiency of red cells 11.0
18 cyclic vomiting syndrome 11.0
19 alpha-thalassemia 11.0
20 capillary malformation-arteriovenous malformation 1 11.0
21 erythroderma, ichthyosiform, congenital reticular 11.0
22 majeed syndrome 11.0
23 beta-thalassemia 11.0
24 macular dystrophy with central cone involvement 11.0
25 paroxysmal nocturnal hemoglobinuria 11.0
26 thalassemia 11.0
27 lepromatous leprosy 11.0
28 congenital dyserythropoietic anemia 11.0
29 waardenburg's syndrome 11.0
30 hypochromic microcytic anemia with iron overload 11.0
31 methylmalonic acidemia with homocystinuria 11.0
32 alagille syndrome 1 10.9
33 hashimoto thyroiditis 10.9
34 klippel-trenaunay-weber syndrome 10.9
35 systemic lupus erythematosus 10.9
36 chromosome 5q deletion syndrome 10.9
37 motion sickness 10.9
38 noonan syndrome 1 10.9
39 optic atrophy 3, autosomal dominant 10.9
40 paget disease, extramammary 10.9
41 pheochromocytoma 10.9
42 sturge-weber syndrome 10.9
43 atransferrinemia 10.9
44 folate malabsorption, hereditary 10.9
45 glutamate formiminotransferase deficiency 10.9
46 ghosal hematodiaphyseal dysplasia 10.9
47 hemolytic uremic syndrome, atypical 1 10.9
48 thiamine-responsive megaloblastic anemia syndrome 10.9
49 myeloma, multiple 10.9
50 neuroblastoma 1 10.9

Graphical network of the top 20 diseases related to Posttransplant Acute Limbic Encephalitis:



Diseases related to Posttransplant Acute Limbic Encephalitis

Symptoms & Phenotypes for Posttransplant Acute Limbic Encephalitis

Drugs & Therapeutics for Posttransplant Acute Limbic Encephalitis

Drugs for Posttransplant Acute Limbic Encephalitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 223)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
2
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
3
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
4
Lactulose Approved Phase 4 4618-18-2 11333
5
Sodium citrate Approved, Investigational Phase 4 68-04-2
6
Sorbitol Approved Phase 4 50-70-4 5780
7
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
8
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
9
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
10
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12
Polyestradiol phosphate Approved Phase 4 28014-46-2
13
Pantoprazole Approved Phase 4 102625-70-7 4679
14
Calcium carbonate Approved, Investigational Phase 4 471-34-1
15
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
16
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
17
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
19
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
20
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
21
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
22 Opiate Alkaloids Phase 4
23 Pharmaceutical Solutions Phase 4
24 Hormones Phase 4
25 Gastrointestinal Agents Phase 4
26 Antiemetics Phase 4
27 Hormone Antagonists Phase 4
28 Autonomic Agents Phase 4
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
30 Anti-Inflammatory Agents Phase 4
31 Anti-Bacterial Agents Phase 4
32 Citrate Phase 4
33 Antineoplastic Agents, Hormonal Phase 4
34 Nucleic Acid Synthesis Inhibitors Phase 4
35 Antacids Phase 4
36 Vaccines Phase 4
37 Anti-Ulcer Agents Phase 4
38 Cathartics Phase 4
39 Reverse Transcriptase Inhibitors Phase 4
40 Anti-HIV Agents Phase 4
41 Anti-Retroviral Agents Phase 4
42 Laxatives Phase 4
43 Contraceptives, Oral Phase 4
44 Contraceptive Agents Phase 4
45 Contraceptives, Oral, Combined Phase 4
46 Norgestimate, ethinyl estradiol drug combination Phase 4
47 Estradiol 3-benzoate Phase 4
48 Estradiol 17 beta-cypionate Phase 4
49 Calcium, Dietary Phase 4
50 Dextrans Phase 4

Interventional clinical trials:

(show top 50) (show all 89)
# Name Status NCT ID Phase Drugs
1 Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial Unknown status NCT00615875 Phase 4 naproxen;placebo
2 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate. A Randomized Controlled Trial Unknown status NCT02278081 Phase 4 lansoprazole;placebo
3 A Phase IV Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral Digital Subtraction Angiography (DSA) Completed NCT00740207 Phase 4 VISIPAQUE 270;Isovue 250
4 Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion) Completed NCT01451034 Phase 4
5 Blood Glucose Response After Oral Intake of Lactulose (Laevolac®) in Mildly Constipated Patients With Diabetes Mellitus Type 2 Completed NCT03666546 Phase 4 Lactulose crystals 20 g;Lactulose crystals 30 g;Lactulose liquid 20 g;Lactulose liquid 30 g;Glucose;Still water
6 An Open-label Single-Center, 4-Period William's Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects Completed NCT02634073 Phase 4 Lamivudine;Sorbitol
7 Ivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan Completed NCT02241044 Phase 4
8 An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
9 Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq® and Rotarix® Completed NCT01266850 Phase 4
10 A Two Different Chemoprophylaxis Approaches After Phacoemulsification Surgery in One Thousand Patients in Iraq :a Clinical Trial Completed NCT03634852 Phase 4 Moxifloxacin hydrochloride 0.5% eye drops;Dexamethasone 0.1% eye drops;Intracameral Moxifloxacin 0.1%;Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml
11 A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures. Active, not recruiting NCT02056288 Phase 4 Fentanyl;Ropivacaine
12 a Randomized, Double Blind, Placebo-controlled, Multicenter Clinical Trial of Efficacy and Safety of Shu Gan yi Yang Capsule in the Treatment of Depression Associated With Erectile Dysfunction (Stagnation of Liver qi and Kidney Deficiency) Not yet recruiting NCT03290313 Phase 4 shu gan yi yang capsule;shu gan yi yang capsule simulation agent
13 Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Terminated NCT01402219 Phase 4 Iopamidol injection 76%;iodixanol
14 RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients) Terminated NCT00782639 Phase 4 Iopamidol injection 76%;iodixanol
15 Performance Proof of The Norma-Sense Gen 3 - Wearing Study Unknown status NCT01542606 Phase 3
16 Open Label, Phase III Safety, Efficacy, and Pharmacokinetic Study of NABI-IGIV 10% [Immune Globulin Intravenous (Human), 10%] in Subjects With Primary Immune Deficiency Disorders (PIDD) Completed NCT00538915 Phase 3
17 An Open Label, Randomised, Three Arm, Single Dose, Multicentre, Parallel Group Study in Healthy Subjects to Compare the Pharmacokinetics of Subcutaneous Mepolizumab When Delivered as a Liquid Drug Product in a Safety Syringe or an Auto Injector With a Reconstituted Lyophilised Drug Product From a Vial Completed NCT03014674 Phase 3
18 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of an Autoinjector for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 204959) Completed NCT03099096 Phase 3 Mepolizumab
19 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667) Completed NCT03021304 Phase 3 Mepolizumab
20 A 52-week, Phase III, Open-label, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease Completed NCT02791763 Phase 2, Phase 3 1 to 4 mg tablets of GSK1278863;6 mg GSK1278863 tablet;Epoetin beta pegol
21 Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure Recruiting NCT03175016 Phase 2, Phase 3 Irinotecan
22 A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib Recruiting NCT03459534 Phase 3 Radotinib HCl
23 A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease Active, not recruiting NCT02697734 Phase 3 osilodrostat;osilodrostat Placebo
24 A Randomised, Double-blind, Parallel Group PhIII Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab as an Add on to Maintenance Treatment in Adults With Severe Bilateral Nasal Polyps - SYNAPSE (StudY in NAsal Polyps Patients to Assess the Safety and Efficacy of Mepolizumab) Active, not recruiting NCT03085797 Phase 3 Mepolizumab;Placebo;Mometasone furoate
25 A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Completed NCT02045797 Phase 2 GSK2140944 Lyophile;GSK2140944 Capsules
26 A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae Completed NCT02294682 Phase 2 GSK2140944
27 A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study to Evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients With Severe Asthma Completed NCT00843193 Phase 2 INTRAVENOUS GSK679586;INTRAVENOUS PLACEBO;FLUTICASONE PROPIONATE
28 Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD) Completed NCT02702817 Phase 2 Naproxen;Placebo
29 Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Completed NCT02015754 Phase 2 DEBIRI
30 The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis Completed NCT02448082 Phase 2
31 A Pilot Phase 1/2, Double Blind, Parallel Group, Controlled Study of the Safety, Tolerability and Preliminary Efficacy Evaluation of Intravitreally Administered Pfenex Ranibizumab Biosimilar Versus Lucentis for the Treatment of Neovascular AMD Completed NCT02121353 Phase 1, Phase 2 Lucentis;PF582
32 A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B Completed NCT01838655 Phase 1, Phase 2 Nitisinone
33 Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers Completed NCT00066066 Phase 2 Metronidazole;Amoxicillin;Doxycycline
34 A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602). Recruiting NCT03177239 Phase 2 Nivolumab;Ipilimumab
35 A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies Recruiting NCT02090114 Phase 2 Testosterone cypionate;Testosterone Enanthate;Abiraterone acetate;Enzalutamide (Cohort A = CLOSED TO ACCRUAL)
36 COMbination of Bipolar Androgen Therapy and Nivolumab in Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT03554317 Phase 2 Testosterone cypionate;Nivolumab
37 High Dose Testosterone in Men With Advanced Prostate Cancer and Homologous Recombination Deficiency Recruiting NCT03522064 Phase 2 Testosterone Enanthate
38 Examining an Intervention to Reduce Underage DUI and Riding With Impaired Drivers Active, not recruiting NCT03506880 Phase 2
39 An Open-Label, Phase II, Study to Evaluate Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Receiving Treatment With Trastuzumab in Combination With Lapatinib or Chemotherapy (EGF117165) Active, not recruiting NCT02213042 Phase 2 Lapatinib
40 A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Active, not recruiting NCT02286921 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone Enanthate
41 A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously Administered ILB Will be Evaluated in Patients With Amyotrophic Lateral Sclerosis Enrolling by invitation NCT03613571 Phase 2 ILB
42 Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients Terminated NCT01808261 Phase 2 GSK249320 100/mg;Placebo
43 A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery Terminated NCT02221037 Phase 2 GSK2862277;Placebo
44 A Phase II Study of Irinotecan HCI in Patients With Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Terminated NCT00360828 Phase 2 Irinotecan Hydrochloride (HCI) Treatment;Continued Irinotecan Hydrochloride (HCI) Treatment
45 A Two Part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren's Syndrome Withdrawn NCT03239600 Phase 2 GSK2618960 2 mg/kg;Placebo;Methotrexate
46 A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects Completed NCT00460707 Phase 1 Casopitant 150 mg;Ketoconazole;Casopitant 150 mg matching placebo;Casopitant 50 mg;Casopitant 50 mg matching placebo
47 An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Completed NCT01934205 Phase 1 GSK2140944 (Single dose);GSK2140944 (Multiple dose)
48 A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement Completed NCT01962454 Phase 1 Deuterated Water;Testosterone enanthate;Placebo to match testosterone enanthate
49 A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector Completed NCT01894360 Phase 1 Belimumab 200 mg/mL
50 Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated FGF Pathway Signaling Completed NCT01868022 Phase 1 GSK3052230;paclitaxel;carboplatin;docetaxel;pemetrexed;cisplatin

Search NIH Clinical Center for Posttransplant Acute Limbic Encephalitis

Genetic Tests for Posttransplant Acute Limbic Encephalitis

Anatomical Context for Posttransplant Acute Limbic Encephalitis

MalaCards organs/tissues related to Posttransplant Acute Limbic Encephalitis:

41
Skin, Liver, Breast, Kidney, Bone, T Cells, Eye

Publications for Posttransplant Acute Limbic Encephalitis

Articles related to Posttransplant Acute Limbic Encephalitis:

(show top 50) (show all 7998)
# Title Authors PMID Year
1
A lysosome-targetable fluorescent probe for imaging trivalent cations Fe3+, Al3+ and Cr3+ in living cells. 38
31207489 2019
2
Mucilaginibacter terrigena sp. nov. sp., A Novel Member of the Family Sphingobacteriaceae. 38
31350573 2019
3
Predictive value of dermoscopy for the treatment of port-wine stains with large spot 532 nm laser. 38
30860283 2019
4
Optical Coherence Tomography Angiography of a Pale Optic Disc in Demyelinating Optic Neuritis and Ischemic Optic Neuropathy. 38
30893268 2019
5
Parasitic pneumonia caused by Paragonimus spp. in a wild Royal Bengal Tiger, Mysuru, South India. 38
31406421 2019
6
Post-treatment of Fungal Biomass to Enhance Pigment Production. 38
30957195 2019
7
Consequences of policy incoherence: how Zambia's post-FCTC investment policy stimulated tobacco production. 38
31053789 2019
8
Starch structure-property relations as a function of barley germination times. 38
31233794 2019
9
Mitochondrial Membrane Protein Associated Neurodegeneration   (MPAN) with a Novel C19orf12 Mutation in the First Decade of Life. 38
30825065 2019
10
Onychomatricoma Micropapilliferum, a New Variant of Onychomatricoma: Clinical, Dermoscopical, and Histological Correlations (Report of 4 Cases). 38
31436573 2019
11
Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study. 38
31135486 2019
12
Glaciihabitans arcticus sp. nov., a psychrotolerant bacterium isolated from Arctic soil. 38
31210627 2019
13
Sociability and pair-bonding in gerbils: a comparative experimental study. 38
31413709 2019
14
A splicing mutation in PHKG1 decreased its expression in skeletal muscle and caused PSE meat in Duroc × Luchuan crossbred pigs. 38
31179574 2019
15
Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms. 38
31161927 2019
16
Substituent effect on colorimetric detection of biologically and environmentally relevant anions: Insight in real-life applications. 38
31078819 2019
17
Traumatic Staphylococcus gallinarum endophthalmitis and detachment of a pallid retina. 38
31434672 2019
18
Antisynthetase syndrome presenting as interstitial lung disease: a case report. 38
31376837 2019
19
Ocular and cerebral infarction from periocular filler injection. 38
30376386 2019
20
Pyrimidine Salvage: Physiological Functions and Interaction with Chloroplast Biogenesis. 38
31101721 2019
21
Generation of Yellow Flowers of the Japanese Morning Glory by Engineering Its Flavonoid Biosynthetic Pathway toward Aurones. 38
31135027 2019
22
Genome-wide identification and analysis of the MADS-box gene family and its potential role in fruit development and ripening in red bayberry (Morella rubra). 38
31425741 2019
23
Synthesis of water treatment sludge ash-based geopolymers in an Amazonian context. 38
31421479 2019
24
Histological and morphometric study of the components of the sinus and atrioventricular nodes in horses and dogs. 38
31421508 2019
25
OsDGD2β is the Sole Digalactosyldiacylglycerol Synthase Gene Highly Expressed in Anther, and its Mutation Confers Male Sterility in Rice. 38
31414258 2019
26
Swept-source optical coherence tomography angiography of choroidal neovascularization in vertically oriented oval dome-shaped maculopathy. 38
31332147 2019
27
Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise. 38
31407088 2019
28
Zfat Is Indispensable for the Development of Erythroid Cells in the Fetal Liver. 38
31366551 2019
29
A new colorimetric and fluorescent probe based on Rhodamine B hydrazone derivatives for cyanide and Cu2+ in aqueous media and its application in real life. 38
31051424 2019
30
Association of Sinonasal Factors With Chronic Laryngitis in Korean Adults. 38
31415057 2019
31
Chronic GI bleeding in a middle-aged woman. 38
30554158 2019
32
[Pure red cell aplasia in children: a clinical analysis of 16 cases]. 38
31416501 2019
33
Two Cases of Equine Multinodular Pulmonary Fibrosis in Japan. 38
31375158 2019
34
Immunolocalization of DMRTB1 in human testis with normal and impaired spermatogenesis. 38
30920770 2019
35
Introducing a mammalian nerve-muscle preparation ideal for physiology and microscopy, the transverse auricular muscle in the ear of the mouse. 38
31351140 2019
36
Thermoflavimicrobium daqui sp. nov., a thermophilic microbe isolated from Moutai-flavour Daqu. 38
31310191 2019
37
Thermus caldilimi sp. nov., a thermophilic bacterium isolated from a geothermal area. 38
31363874 2019
38
Sharpening species boundaries in the Micarea prasina group, with a new circumscription of the type species M. prasina. 38
31099728 2019
39
Preparation and Characterization of Self Nano-Emulsifying Drug Delivery System Loaded with Citraland Its Antiproliferative Effect on Colorectal Cells In Vitro. 38
31323842 2019
40
Gaping of pectoralis minor muscles: magnitude and characterization of an emerging quality issue in broilers. 38
31347671 2019
41
DNA-based predictive models for the presence of freckles. 38
31400656 2019
42
How many cell types form the epithelial lining of the human uterine tubes? Revision of the histological nomenclature of the human tubal epithelium. 38
31009685 2019
43
Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases. 38
31279344 2019
44
[An infant with prolonged jaundice]. 38
31361416 2019
45
Molecular and Functional Characterization of Oryza sativa Flavonol Synthase (OsFLS), a Bifunctional Dioxygenase. 38
31244203 2019
46
Detection and Crystal Structure of Hydrogenated Bipentacene as an Intermediate in Thermally Induced Pentacene Oligomerization. 38
31244161 2019
47
In the Pale Red Light: Control of pre-mRNA Splicing by RRC1 and SFPS. 38
31266847 2019
48
Isoelectric solubilization/precipitation processing modified sarcoplasmic protein from pale, soft, exudative-like chicken meat. 38
30857676 2019
49
A Redox-Switchable Colorimetric Probe for "Naked-Eye" Detection of Hypochlorous Acid and Glutathione. 38
31277409 2019
50
A semen cassia gum-based film with visual-olfactory function for indicating the freshness change of animal protein-rich food. 38
30974141 2019

Variations for Posttransplant Acute Limbic Encephalitis

Expression for Posttransplant Acute Limbic Encephalitis

Search GEO for disease gene expression data for Posttransplant Acute Limbic Encephalitis.

Pathways for Posttransplant Acute Limbic Encephalitis

GO Terms for Posttransplant Acute Limbic Encephalitis

Sources for Posttransplant Acute Limbic Encephalitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....